Topic: Bristol-Myers Squibb Company
(Reuters) - Bristol-Myers Squibb Co said on Thursday its liver cancer drug brivanib failed to meet the primary endpoint in a late-stage clinical trial.Brivanib failed to meet the main goal of improving overall survival versus placebo in liver cancer patients who failed ...
NEW YORK (Reuters) - Bristol-Myers Squibb Co and Johnson & Johnson plan to jointly develop experimental treatments for hepatitis C in a market worth billions of dollars.The drugs being developed by the two companies work by blocking different proteins than those attacked ...
New data on multiple Bristol-Myers Squibb Company (NYSE:BMY) compounds will be presented at the 61st annual meeting of the American Association for the Study of Liver Diseases (AASLD) in Boston from October 29 to November 2. "Bristol-Myers Squibb is focused on developing ...
Photo Gallery
From Around the Web
Video Gallery
-
Company Profile: Bristol-Myers Squibb Company (NYS...
The company's blockbuster cardiovascular line-up includes heart disease drug ...2010-04-21 -
Bristol-Myers Bids $5.2B For ImClone ...
Bristol-Myers Squibb Company has offered to buy ImClone Systems Inc ...2008-08-01 -
Analyst Insight: Morgan Stanley Downgraded Bristol...
Morgan Stanley analysts are downgrading Bristol-Myers Squibb (NYSE:BMY) to ...2010-10-04
